Posted On: 08/22/2015 5:37:07 PM
Post# of 72443
Or maybe Dr. Menon gave those mice a fake white coat lol.
Besides efficacy, I don't expect P to have any safety issues since it converts to abacavir, an approved drug with a long safety profile. The 505(b)(2) designation expedites the trials and adds great value to the drug if it's approved.
Besides efficacy, I don't expect P to have any safety issues since it converts to abacavir, an approved drug with a long safety profile. The 505(b)(2) designation expedites the trials and adds great value to the drug if it's approved.
(0)
(0)
Scroll down for more posts ▼